Dr. John LaRosa from SUNY Downstate Medical Center moderated the topic "The HDL Quandary" with Drs. Nathan Wong from the University of California, Irvine, Antonio Gotto from Weill Cornell Medical College, and Daniel J. Rader from the University of Pennsylvania, participating.
The discussion focused primarily on:
- The reliability of high-density lipoprotein (HDL) as a biomarker for atherosclerosis risk;
- the appropriateness of measuring HDL concentration, HDL particles, or HDL function (eg, cholesterol efflux capacity) as a measure of risk;
- clinical trials examining HDL increase as a therapeutic strategy;
- beneficial properties of HDL;
- new antiatherogenic drugs; and
- the relative usefulness of obtaining HDL measurements in clinical practice.
(Med Roundtable Cardiovasc Ed. 2014;4(1):e25–e31) ©2014 FoxP2Media, LLC